Botulinium Toxins

Botulinum toxin is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction, thus causing flaccid paralysis. The toxin causes the disease botulism. The toxin is also used commercially for medical and cosmetic purposes.

Read more
Filter

Rentox


Read more

Nabota

Nabota, which originated from wild-type Clostridium botulinum, is produced by the guideline of WHO GMP. Nabota was approved by the Korean FDA in 2013, launched in 2014 and contracted for export to 90 countries. Nabota is indicated for the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm, hemifacial spasm or VIIth nerve disorders in patients 12 years or older.

Read more

Innotox

Innotox is a type A botulinum toxin developed by the South Korean company Medytox Inc. It is the world's first liquid injectable form of botulinum Toxin type A approved by KFDA in South Korea, in 2013. Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan.  It is produced in compliance with all international GRM standards and the conditions for the production of biological substances.

Read more

Botulax

Botulax is a type A botulinum toxin from international pharmaceutical South Korean company Hugel Inc which has been successfully manufacturing innovative aesthetic and clinical cosmetology products for 20 years. Botulax is highly appreciated by cosmetologists for its long-lasting effect, quick action, and safety. The line contains 2 products Botulax 100 ui and Botulax 200 ui.

Read more

Rentox


Read more